SNTI icon

Senti Biosciences
SNTI

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$9.5
788% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Chardan Capital
Chardan Capital
Geulah Livshits
25% 1-yr SNTI win rate
9 Dec ‘25 1 month ago
Leerink Partners
Leerink Partners
Jeffrey La Rosa
0% 1-yr SNTI win rate
21 Nov ‘25 2 months ago